One hundred and twenty cases of enduring sexual dysfunction following treatment

International Journal of Risk and Safety in Medicine

Volumn 26, Issue 2, 2014, Pages 109-116

  Hogan, Carys ^a   Le Noury, Joanna ^a   Healy, David ^a   Mangin, Derelie ^b  

^a BANGOR UNIVERSITY   (United Kingdom)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

erectile dysfunction; finasteride; genital anesthesia; isotretinoin; loss of libido; SSRIs

Indexed keywords

AMFEBUTAMONE; BUPRENORPHINE; BUSPIRONE; CITALOPRAM; DESVENLAFAXINE; DEXAMPHETAMINE; DULOXETINE; ESCITALOPRAM; FINASTERIDE; FLUOXETINE; FLUVOXAMINE; GOSERELIN; HALOPERIDOL; ISOTRETINOIN; LAMOTRIGINE; LEUPRORELIN; LITHIUM; MIRTAZAPINE; NEFAZODONE; OLANZAPINE; ONDANSETRON; PAROXETINE; QUETIAPINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TESTOSTERONE; TRAZODONE; UNINDEXED DRUG; VENLAFAXINE; ZIPRASIDONE; KERATOLYTIC AGENT; STEROID 5ALPHA REDUCTASE INHIBITOR;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CLINICAL FEATURE; DOPAMINERGIC SYSTEM; ENDOCRINE SYSTEM; FEMALE; GENDER; HUMAN; IMPOTENCE; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHYSIOLOGY; PRIAPISM; SEROTONINERGIC SYSTEM; SEXUAL DYSFUNCTION; SYMPTOMATOLOGY; TREATMENT DURATION; VALIDITY; CHEMICALLY INDUCED; MIDDLE AGED; YOUNG ADULT;

5-ALPHA REDUCTASE INHIBITORS; ADOLESCENT; ADULT; AGED; FEMALE; FINASTERIDE; HUMANS; ISOTRETINOIN; KERATOLYTIC AGENTS; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; YOUNG ADULT;

EID: 84902276204     PISSN: 09246479     EISSN: 18786847     Source Type: Journal    
DOI: 10.3233/JRS-140617     Document Type: Article

References (17)

1. Bahrick AS. Post SSRI sexual dysfunction. American Society for the Advancement of Pharmacotherapy Tablet. 2006;7(3):2-3, 10-11.
2. Csoka AB, Shipko S. Persistent sexual side effects after SSRI discontinuation. Psychotherapy and Psychosomatics. 2006;75:187-8. doi:10.1159/000091777
3. Bahrick AS. Persistence of sexual dysfunction side effects after discontinuation of antidepressant medications: Emerging evidence. The Open Psychology Journal. 2008;1:42-50.
4. Csoka AB, Bahrick A, Mehtonen O-P. Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors. Journal of Sexual Medicine. 2008;5:227-33. doi:10.1111/j.1743-6109.2007.00630.x
5. Irwig M. Persistent Sexual Side Effects of Finasteride: Could They Be Permanent? J Sex Med. 2012; p. (http://www.ncbi.nlm.nih.gov/pubmed/22789024)
6. Irwig M, Kolukula S. Persistent sexual side effects of finasteride for male pattern hair loss. J Sex Med. 2011; pp. 1747-53 (http://www.ncbi.nlm.nih. gov/pubmed/21418145)
7. Tirado Sánchez A, Léon Dorantes G. [Erectile dysfunction during isotretinoin therapy]. http://www.ncbi.nlm. nih.gov/pubmed/16447596
8. Rossi M, Pellegrino M. Acitretin-associated erectile dysfunction: A case report http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783159/
9. Csoka AB, Szyf M. Epigenetic side-effects of common pharmaceuticals: A potential new field in medicine and pharmacology. Med Hypotheses. 2009;73(5):770-80. doi:10.1016/j.mehy.2008.10.039. PMID 19501473.
10. Damsa C, Bumb A, Bianchi-Demicheli F, et al. Dopamine-dependent side effects of selective serotonin reuptake inhibitors: A clinical review. J Clin Psychiatry. 2004;65(8):1064-8. doi:10.4088/JCP.v65n0806. PMID 15323590.
11. Sukoff Rizzo SJ, Pulicicchio C, Malberg JE, et al. 5-HT(1A) receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in rats. Int J Neuropsychopharmacol. 2009;12(8):1045-53. doi:10.1017/S1461145709000406. PMID 19435548.
12. Hsieh JT. Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: Implications for chemoprevention of prostate cancer. Prostate 2011;71:1115-21 (http://www.ncbi.nlm.nih.gov/pubmed/ 21557276)
13. Hines RN, Adams J, Buck GM, Faber W, Holson JF, Jacobson SW, Keszler M, McMartin K, Segraves RT, Singer LT, Sipes IG, Williams PL. NTP-CERHR Expert panel report on the reproductive and developmental toxicity of fluoxetine. NIH Publication No. 05-4471. 2004; pp. 1-211.
14. Safarinejad MR. Evaluation of endocrine profile and hypothalamic- pituitary-testis axis in selective serotonin reuptake inhibitor-induced male sexual dysfunction. J Clin Psychopharmacol. 2008;28(4):418-23. doi:10.1097/JCP.0b013e31817e6f80. PMID 18626269.
15. Safarinejad MR. Sperm DNA damage and semen quality impairment after treatment with selective serotonin reuptake inhibitors detected using semen analysis and sperm chromatin structure assay. J Urol. 2008;180(5):2124-8. doi:10.1016/j.juro.2008.07.034. PMID 18804223.
16. Akasheh G, Sirati L, Kamran ARN, Sepehrmanesh Z. Comparison of the Effect of Sertraline With Behavioral Therapy on Semen Parameters in Men With Primary Premature Ejaculation. 2014. http://dx.doi.org/10.1016/j.urology.2013.12.004
17. O'Reilly KC, Trent S, Bailey SJ, et al. 13 cis-retinoic acid alters intracellular serotonin, increases 5HT-1a receptor, and serotonin reuptake transporter levels in vitro. Exp Biol Med. 2007;232:1195-203.